HOME >> MEDICINE >> NEWS
Mecca pilgrims a priority for meningococcal vaccination

N.B. Please note that if you are outside North America the embargo date for Lancet press material is 0001 hour UK time Friday 15th February 2002.

Muslims travelling to Saudi Arabia for the annual Hajj religious festival are a high priority for enhanced meningococcal vaccination this year. Thirty-three cases and nine fatalities were reported in England and Wales, a similar number to that reported in 2000, despite the recommendation to use a different vaccine in 2001. Better implementation of control policies are needed to prevent an outbreak of meningococcal disease among pilgrims and their contacts this year, conclude authors of a research letter in this weeks issue of THE LANCET.

An outbreak of a previously rare strain (W135) meningococcal disease was seen in 2000 and 2001 among pilgrims returning from Saudi Arabia and their contacts. The Public Health Laboratory Service (covering England and Wales) set up enhanced surveillance to monitor spread and virulence of the outbreak strain, and to collect data on case characteristics. The incidence of disease amongst pilgrims reported from England and Wales in 2001 was similar (28 per 100,000) to the rate reported during 2000 (30 per 100,000), despite a change in the recommendation for pilgrims to receive the quadrivalent vaccine instead of the bivalent vaccine recommended in 2000. Both the recommendation and vaccine were not available until January, 2001, and coverage among pilgrims to the Hajj 2001 was low (below 47%). The casefatality ratio was high (20%), and sustained transmission of the virulent outbreak strain was seen.

Mary Ramsay of the PHLS comments: This outbreak is characterised by a high case-fatality rate that might reflect the virulence of the strain or characteristics of this group of patients. As well as primary prevention, attempts should be made to improve outcome. Preadmission treatment of suspected meningococcal disease in primary care with intravenous benzylpen
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-0-20-7611-4076
Lancet
14-Feb-2002


Page: 1 2

Related medicine news :

1. All Hajj pilgrims should get meningitis jab
2. Child health must become UNICEFs priority over next decade
3. Vaccine development against influenza A (h5n1) virus should be made a priority
4. NPSF makes safe use of pharmaceuticals a national health priority
5. NOVANTRONE application for multiple sclerosis granted priority review by FDA
6. Infectious disease researcher available to discuss new federal recommendations aimed at protecting college students from meningococcal meningitis
7. Many children are undervaccinated or have delayed vaccinations in their first 2 years of life
8. Influenza vaccination programmes for children in USA and Canada based on little evidence
9. Flu vaccination benefits people of any age with high-risk medical conditions
10. Flu vaccination impact on elderly deaths may be over-estimated
11. Risk factors affect parents attitudes about STD vaccinations

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mecca pilgrims priority for meningococcal vaccination

(Date:11/21/2014)... (PRWEB) November 21, 2014 Even with years ... something to learn and room for growth, participating in two ... from State Farm’s National Convention, a networking event with the ... the country, bringing back the latest and greatest in insurance ... have spotted Kirk and his team (Stacy, Anthony, Reina and ...
(Date:11/21/2014)... New York, NY (PRWEB) November 21, 2014 ... financial burden for its intended parents — and at the ... Providing a renewed sense of optimism for future parents across ... of success. , Prospective parents today are zoning in ... However, beyond the encumbering costs, are individuals over-stressing clinical ...
(Date:11/21/2014)... Palm Beach, FL (PRWEB) November 21, 2014 ... report issued on June 11th, 2014, the ... Corporation can rupture when the airbag inflates. The force ... into metal shrapnel, and the metal shards may pierce ... within the vehicle’s cabin. , According to a ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 Nature’s Sleep is excited ... contest . The contest calls for the creation of any type ... photo — that encompasses sleep, a bed or a mattress. ... said Alan Hirschhorn, Vice President of Marketing for Nature’s Sleep, “that ... array of more than 10,000 creative entries from some very talented ...
(Date:11/21/2014)... HealthDay Reporter THURSDAY, Nov. ... tasks may help preserve thinking skills and memory as ... researchers compared IQ scores obtained around age 11 from ... reasoning scores around age 70. The scientists found that ... sharper thinking even years after retirement. Researchers ...
Breaking Medicine News(10 mins):Health News:Kirk Martin Insurance Agency Goes Local and National with State Farm 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 2Health News:CARE Surrogacy Center Reports on its Multiple Measures of Success 3Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 2Health News:Takata Airbag Recall Class Action Lawsuit Resource Released by Florida Injury Attorney 3Health News:Nature’s Sleep Kicks Off their 2nd Art Of Sleep Contest 2Health News:Could Your Job Help Preserve Your Aging Brain? 2Health News:Could Your Job Help Preserve Your Aging Brain? 3
(Date:11/21/2014)... MONTREAL , 21. November 2014 ... hat heute bekannt gegeben, dass ... – EMA) die Kennzeichnung als Orphan-Medizinprodukt ... Produktkandidat des Unternehmens zur Behandlung von ... eine seltene, stark beeinträchtigende genetische Krankheit, ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... , Chief Executive Officer, will be presenting at the 26 ... York Palace Hotel in New York . ... at 2:00 PM ET. In addition, Mr. Krakauer and ... for separate one-on-one meetings during the day. ...
(Date:11/21/2014)... -- Depomed, Inc. (NASDAQ: DEPO ) today announced that ... Annual Healthcare Conference in New York City . ... for 8:00 am EST (5:00 am PST) on Tuesday December 2, ... accessed via the Investor Relations page of the Depomed website at ... for 30 days on the company,s website. About ...
Breaking Medicine Technology:Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 2Clementia Pharmaceuticals erhält EMA-Kennzeichnung als Orphan-Medizin für Palovarotene zur Behandlung von Fibrodysplasia ossificans progressiva 3Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2
Cached News: